Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 143,985 | reported | 05 Mar 2026 | tx 44+1,339,248−264,066 |
| Alkermes plc. | 0 | reported | 14 May 2020 | tx 482+2,975,157−1,917,074 |
| ALKERMES INC | 0 | reported | 16 Sept 2011 | tx 246+1,509,674−2,046,286 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 35+197,180−108,464 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 95,990 | 0.00 USD | |
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 143,985 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 7,909 | 14.52 USD | |
| 02 Feb 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 3,557 | 14.65 USD | |
| 06 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 3,326 | 11.11 USD | |
| 30 Sept 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 10,558 | 14.65 USD | |
| 31 Jul 2025 | TENDER | Sage Therapeutics, Inc. | 2,845 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 21,500 | — | deriv |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 19,154 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 21,500 | 0.00 USD | deriv |
| 31 Mar 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 10,896 | 3.47 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 68,420 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 102,630 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 19,154 | 0.00 USD | deriv |
| 12 Sept 2024 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 40,000 | 2.53 USD | first after silence |
| 10 Jun 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 16 Apr 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 91,180 | 0.00 USD | |
| 16 Apr 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 120,000 | 0.00 USD | deriv |
| 05 Mar 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 1,792 | 18.73 USD | |
| 26 Feb 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 40,000 | 0.00 USD | |
| 26 Feb 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 60,000 | 0.00 USD | deriv |
| 09 Jan 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 2,716 | 16.33 USD | |
| 03 Jan 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 4,925 | 0.00 USD | deriv |
| 31 Oct 2023 | GIFT | Amylyx Pharmaceuticals, Inc. | 11,072 | 0.00 USD | |
| 23 Aug 2023 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 18,165 | 6.88 USD |
2 purchases reported after at least 12 months of silence — most recent on 12 Sept 2024.